Skip to main content
Clinical Trials/NCT04063072
NCT04063072
Unknown
Not Applicable

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy of Benign or Malignant Tumors of the Uterus. A Stepped-wedge Cluster Randomized Clinical Trial.

Ospedale Regina Montis Regalis1 site in 1 country1,800 target enrollmentSeptember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uterine Neoplasms
Sponsor
Ospedale Regina Montis Regalis
Enrollment
1800
Locations
1
Primary Endpoint
Length of stay
Last Updated
4 years ago

Overview

Brief Summary

The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.

Detailed Description

ERAS (Enhanced Recovery After Surgery) protocol is a multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery. Even if efficacy and safety of ERAS protocol in gynaecological surgery is well-established in the literature, its implementation is limited to few selected centres in Piemonte. The aim of the study is to extend the implementation of the ERAS protocol to whole regional network of hospitals. Specific objectives are to estimate its impact on different dimensions of quality of care, including length of stay, complications and patient satisfaction, and to identify possible barriers or facilitating factors.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
October 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
Ospedale Regina Montis Regalis
Responsible Party
Principal Investigator
Principal Investigator

Dr. Andrea Puppo

Gynecologists

Ospedale Regina Montis Regalis

Eligibility Criteria

Inclusion Criteria

  • All the hospital wards within the Piemonte Region performing hysterectomy.
  • All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus.

Exclusion Criteria

  • Hospital wards performing less than 20 expected cases per year
  • Emergency hysterectomy
  • Hysterectomy for pelvic floor disorders
  • High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).

Outcomes

Primary Outcomes

Length of stay

Time Frame: 12 days after admission

Mean length of stay calculated as difference between date of discharge and date of admission of the hospitalization for surgery, excluding length of stay \>12 days (98th percentile of the expected distribution).

Secondary Outcomes

  • Length of stay >12 days(30 days after admission)
  • Recovery after surgery(24 hours after surgery)
  • Complications(30 days after discharge)
  • Emergency visits after discharge(30 days after discharge)
  • Transfer to intensive care unit(30 days after surgery)
  • Hospital admissions after discharge(30 days after discharge)
  • Reintervention(30 days after surgery)
  • Healthcare costs(30 days after discharge)
  • Patients' satisfaction(15 days after discharge)

Study Sites (1)

Loading locations...

Similar Trials